Master’s Programme
Pharmaceutical Sciences – Drug Development and Regulatory Affairs
The Master’s Programme in Pharmaceutical Sciences – Drug Development and Regulatory Affairs, in the following referred to as PHARM_SCI, is a joint study programme of the Medical University of Innsbruck and the University of Innsbruck held in English. It provides scientifically substantiated and practice-oriented knowledge of drug development and focuses on the qualitative process of drug authorization.
Detailed Information Advisory Board
The admission procedure PHARM_SCI is organized and conducted by the Medical University of Innsbruck for all applicants, the admission takes place at the Leopold-Franzens-University Innsbruck.
Info
Master of Science (MSc)
Duration/ECTS-Credits
4 semesters/120 ECTS-Credits
Mode of Study
Full-time
Language
English
Requirements
Relevant bachelor's degree or equivalent, language certificates
Curriculum
Information on the curriculum
Admission Procedure
Information
The right degree for me?
Highlights
- Scientific and regulatory aspects of preclinical and clinical drug development
- Regulatory requirements and documentation for marketing authorization
- Safety and pharmacovigilance
- Production and quality aspects of new drugs
- Market access and pharmacoeconomic aspects
Similar studies
University of Innsbruck
Medical University of Innsbruck
- Molecular Medicine
(only held in german)
Post graduation
Direct career entrance or advanced PhD studies in natural and biomedical sciences
My career
My career opportunities
- Pharmaceutical Industry in various fields
- Startups developing new drugs
- Consultancy Services in the Pharmaceutical area
- Clinical Research Organisations
- University Hospitals-Clinical Trial Support
- Regulatory Authorities
- Pharmaceutical Research
- Research and teaching positions at universities
- Further studies: PhD